- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04797663
Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris
Clinical and Dermoscopic Evaluation of Long-pulsed 1064 nm Nd-YAG Laser Versus Trichloroacetic Acid 20% in Treatment of Keratosis Pilaris
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Keratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of skin. It's a very common benign condition that manifests as small, rough folliculocentric keratotic papules, often described as chicken bumps, chicken skin or goose-bumps, in characteristic areas of body, particularly the outer upper arms and thighs.
Trichloreacetic acid (TCA) is a type of chemical peels that is derived from acetic acid by the chlorination of 3 hydrogen ions. It can induce coagulative necrosis of proteins and cells. The depth of action depends on various factors e.g the number of layers applied and its combination with substances that potentiate its action.
Nd: YAG laser is a type of hair removing devices that operates at wave length of 1064nm. This wave length allows for less absorption at the epidermis. It is less absorbed by melanin, which leads to lower side effect and better tolerance but less efficacy in dark skinned patients.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11562
- Kasr Alainy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients above 18 years with KP.
- Patients with KP affecting back of the trunk, arms, thighs, forearms, legs and buttocks.
Exclusion Criteria:
- Pregnant or lactating females.
- Patients who had performed any laser treatment for KP within 6 months prior to the study.
- Patients with history of oral retinoids within 3 months prior to the study.
- Patients with history of hypertrophic scars or keloids.
- Patients who used any topical treatment one month prior to the session.
- Patients with acne affecting the same sites of keratosis pilaris.
- Patients with active skin diseases affecting the area involved with KP e.g. folliculitis and eczema.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nd-YAG laser
laser hair removal
|
laser hair removal device
Other Names:
|
|
Experimental: TCA 20%
chemical peel
|
chemical peel
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of clinical and dermoscopic scores of KP with Nd-YAG laser
Time Frame: 4 months
|
the change in roughness and color of KP by clinical score after 4 sessions of Nd-YAG laser.
the score ranges from 0-4.
where 0 is no change and 4 is excellent improvement
|
4 months
|
|
Change of clinical and dermoscopic scores of KP with TCA 20%
Time Frame: 4 months
|
the change in roughness and color of KP by clinical score after 4 sessions of TCA 20% peel.
the score ranges from 0-4.
where 0 is no change and 4 is excellent improvement
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
safety and tolerability of Nd-YAG laser and TCA 20% in treatment of KP: adverse events
Time Frame: 4 months
|
adverse effects of treatment modalities, if any
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Akmal Saad, professor, Cairo University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- las177
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratosis Pilaris
-
Premier Specialists, AustraliaThe University of New South WalesActive, not recruitingKeratosis PilarisAustralia
-
Northwestern UniversityCompleted
-
Johns Hopkins UniversityRecruitingKeratosis Pilaris (KP)United States
-
Wright State UniversityOnset DermatologicsTerminatedKeratosis PilarisUnited States
-
AOBiome LLCCompletedKeratosis PilarisUnited States
-
Goldman, Butterwick, Fitzpatrick and GroffNot yet recruitingKeratosis Pilaris
-
Premier Specialists, AustraliaRecruitingKeratosis PilarisAustralia
-
Mayo ClinicCompletedPITYRIASIS RUBRA PILARISUnited States
-
Mayo ClinicNot yet recruiting
-
PeplinCompletedSeborrheic KeratosisAustralia
Clinical Trials on Nd-YAG laser
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingChanges in Bacterial Count in Axilla After Laser Hair RemovalEgypt
-
Aljazeera HospitalNational Research Centre, EgyptUnknown
-
Cairo UniversityCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Institute of Dermatology, ThailandCompletedAndrogenetic Alopecia | Hair Loss/BaldnessThailand
-
Kasr El Aini HospitalCompleted
-
Afyon Kocatepe University HospitalCompletedRetinal Degeneration | Macula Edema | Retinal Detachment | Posterior Capsule Opacification | Macular Pigmentation | Choroid Disease | Anterior Chamber Angle Congestion
-
Zealand University HospitalUnknownHyperhidrosis Primary Focal AxillaDenmark